Clin2
NCT07230067Possibly a fitRecruiting

Sepsis with low platelets: platelet transfusion study

SepsisSepsis and Coagulopathy

Part of Blood & lymphatic, Heart & circulation, Infections clinical trials.

This study looks at whether platelet transfusions help patients with sepsis and very low platelet counts recover better. If you or your loved one had sepsis, a low platelet count, and were in the ICU for at least two days, this trial may be relevant.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
1,500 people
Ages
18 years and older
Study type
Observational

Who can take part

  • You were in the ICU for at least 2 days between January 2021 and May 2024.
  • You had sepsis (a severe infection that affects your whole body).
  • Your platelet count was very low (less than 100) when you entered the ICU.
  • You were at least 18 years old at the time.
  • You did not have active bleeding, certain blood cancers, or severe liver or kidney disease.
  • You were not on strong chemotherapy or immunosuppressant drugs before your ICU stay.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07595133Not yet recruiting· Phase 1
Romiplostim for Low Platelets in Sepsis

This study tests a new drug called romiplostim N01 to help raise platelet counts in patients with sepsis (a serious blood infection). Low platelets during sepsis can increase bleeding risk, and this drug may help prevent complications.

NCT07160426Not yet recruiting· Phase 2
Protecting blood vessel lining in severe infections

This trial tests if a special fluid given through a vein can protect and repair the lining of your blood vessels during sepsis. Sepsis is a dangerous reaction to an infection that can damage organs. This study aims to see if this treatment helps patients in the intensive care unit (ICU) recover better.

NCT06854640Recruiting· Phase 1
Safety and dosing study for a new sepsis-related blood clotting treatment

This study tests a new drug (BAY 3389934) for people with sepsis who also have a blood clotting problem. It aims to find the right dose and make sure the drug is safe.

Edegem
NCT07667153Not yet recruiting
Sepsis and bone marrow function study

This study is looking at how sepsis affects bone marrow to understand why some people get very sick. If you are in the ICU with a serious infection or another critical illness, you may be eligible to join.

NCT06599385Not yet recruiting· Phase 3
Platelet transfusions in ICU patients with low platelet counts

This trial tests whether giving platelet transfusions to critically ill patients with very low platelet counts helps prevent bleeding. If you are in the ICU with low platelets and need life support, this study may be relevant to you.

NCT07682246Not yet recruiting
Platelet transfusion study for ICU patients

This trial tests how a platelet transfusion affects blood vessel function in intensive care patients with low platelet counts (thrombocytopenia). It may help doctors understand if transfusions help the tiny blood vessels work better.

Paris

Hear when a new Sepsis trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.